BINEX Co. Ltd (053030.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7053030003
BINEX Co. Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 130.05 bn KRW | 168.47 bn KRW |
| Gross profit | 21.29 bn KRW | 45.07 bn KRW |
| Operating income | -30.75 bn KRW | -4.53 bn KRW |
| EBIT | -36.63 bn KRW | -1.25 bn KRW |
| Net income | -35.07 bn KRW | -3.23 bn KRW |
| Diluted EPS – continuing operations | -1,134.08 KRW | -101.29 KRW |
Full history since 2004, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About BINEX Co. Ltd
BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. It offers bisroot products; GI tract and antispasmodic, and antiulcer agents; NSAIDs; cardiovascular and urology products; hepatic protectors; ointments and creams; ophthalmic solutions; CNS agents; digestive products; constipation and blood circulation products; antibiotic and antifungal agents; cough and cold remedy products; vitamins and nutrients; antihistamine products; antivertigo products; and OTC products. BINEX Co., Ltd. has a co-development partnership with Genexine, Inc. to develop COVID-19 vaccine. The company was founded in 1957 and is based in Incheon, South Korea.
More stocks
- Masterflex (MZX.DE)
- Tri Ocean Textile Co Ltd (1472.TW)
- Upstream Bio, Inc. (UPB)
- Vina San Pedro (VSPT.SN)
- Sandfire Resources America Inc (SFR.V)
- Yg Plus Inc (037270.KS)
- Ferro S.A. (FRO.WA)
- Orvana Minerals Corp. (ORV.TO)
- Namuga Co. Ltd (190510.KQ)
- E-Life Mall Corp (6281.TW)
- 3billion (394800.KQ)
- Croghan Bancshares Inc (CHBH)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.